Populations

Browse more sub-categories

Active Resources: 29

Articles: 1

  • Bictegravir/TAF/FTC in Women

    The single-pill combination of bictegravir (BIC) with tenofovir alafenamide (TAF) and emtricitabine (FTC), recently approved by the FDA, has been shown in four Phase III trials to be effective as initial therapy and as a switch regimen in patients with stably suppressed HIV RNA...

Day Title
5/11
Clinical Case-Aided Led Learning (CALL)
Event type: Webinars
6/8
Clinical Case-Aided Led Learning (CALL)
Event type: Webinars
7/15
11/27
2018 Texas HIV-STD Conference
Day Title
4/20
A Clinic For Us: Community Health Services